Tag | Content |
---|
EnhancerAtlas ID | HS064-04558 |
Organism | Homo sapiens |
Tissue/cell | GM18507 |
Coordinate | chr14:78059400-78061420 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Foxd3 | MA0041.1 | chr14:78060565-78060577 | AAATGTTTGTTT | + | 6.27 | SPI1 | MA0080.4 | chr14:78060106-78060120 | GAAATGAGGAAGTA | + | 6.59 | SPIC | MA0687.1 | chr14:78060106-78060120 | GAAATGAGGAAGTA | + | 6.93 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_09589 | chr14:78056146-78062500 | CD14 | SE_13197 | chr14:78059395-78061447 | CD34_Primary_RO01480 | SE_13603 | chr14:78058600-78061842 | CD34_Primary_RO01536 | SE_14261 | chr14:78058354-78062594 | CD34_Primary_RO01549 | SE_46228 | chr14:78059305-78061529 | Osteoblasts |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr14 | 78061203 | 78061257 | chr14 | 78059840 | 78060228 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH14I077588 | chr14 | 78054408 | 78061397 |
|
Enhancer Sequence | ACGCCACTGT ACTCCAGCCT GGGCGACAGA GTGAGACTCC ATCTCAAAAA AAAAAAAAAT 60 TAAAAAAATT AAAAAATAAG TGAGAATGTG GTATTTGGTC CTCCCGTTTT TAAATATCTG 120 ATCATGAACA AGCTGTGGAG GCAAAATGTT AGTTTAAAAT TTTGTCAGTG TGTGGTAACT 180 ACCTACCATA ATTTACTCCT TACGTTCCTA GCTATTTCCT ATCTAAATAT TAGAATATTT 240 TTTTCTGAAT TAAATTTTTT CATTTTGTAG AGATGAGGTT TCATTATGTT GTGTCAGCTG 300 GTCTCAAACT CCTGGCCTTG AGTGATCCTC CTGCCTCAGC CTAGAACATC TTTATTAATT 360 CAAGCTTTTG CTGTATCTGT CACGTACGTG TTTCTGAACT ACTAGCTTCA CCTCACATCA 420 CAAAGAAATA ATCCATAGAT TGAGAAAAAC AACATTCTCA TCCAAAACAC CACGAATAAC 480 AGAGGATTAA GGGGTAAAGA ATTCCAAGAA TTTTATGCAA TGTATATAAA ATAGAACAAA 540 CTCATGGTAA CTCATCTTTA TTGGTATGAT CATGTGATTT AGTTGTATTC AAAGCAACAT 600 ACGGTATTTC CTTACATCAA AGAATTAACA CAGTTAAACT GGGCTCTCTT TTATAATGAA 660 ATGAGGAAGA AAACCAGGAT GTGGTTATGA ATACCACTCT CTCAGTGAAA TGAGGAAGTA 720 GCAACATTAT GTTTGCATTT TATGATCCCA AGCAACCACT TTCCCTCACC TCCTTCCAGT 780 TTAACACTTA ATTTGCCTCC CTCTTTCCCC ATCTCTAATC CAACATTAGA AAACAAACAT 840 GATCTATCAC AGGAAAGGAA TGACTTTTCC TTTCCCTCTA AAAGCTGAAT TTTTGTAAGA 900 AAATGGCAGA AGTTGGCTGT TTTAAATGCT AATGTTATCT ACTGGGAATA TTCTATTGAA 960 ATGAATTTGA ATAATTTAAT AAAATCCTCT CCATAAACTG CAGAGGCAAA TGCTCTCCTC 1020 AGCCTCCCAT TTCCTTGTAT TACTTCCTCC AAGAATTGTT TCCTGATTAA CCCTATGCTA 1080 CTCAGATACT TTTTTTGTTC TATATCTTCA TATAATCTAA GTATTATTTA CTTGTATAAT 1140 GGTTTTGCAA AGGCCCATAA CTTTCAAATG TTTGTTTCCT CAACAAAATT AGAAACTACT 1200 TAAGAATAAA ATCTGTGTGT TCTAATTCTT TCACACAAAG GATACACAGG CAGCTCCCAA 1260 CACTTAAACC ACCAATTTAC TTTCTGTAAA CATGAAACAA GTTCCAAAGA TAATGTACTC 1320 ACAAAGTAAT TCAGATACAT CTTGTTGGTT TCATTCATTC ATCACACTTT GAGCACCAGC 1380 TGCACAAGCT GTATGAAAAA TCCCCTGATC AAAAACTGCC CTTGGGGTCA TGGTGGCTCA 1440 CTCCTATAAT CCCAACACTT TGGGAGGCCA AGGCAGGAGG ATCGCTTGAG CACAGGAGTT 1500 TGAGACCAGC CTGGGCAACA TGGCGAGACG CTGTCTCTAT TTAAAAACAA AAACAAAAAC 1560 AATACTCCTC ATTGCCTACC AAACTTCTTA CTTTGATTTT CAAAACACAA TTTCTCTTCT 1620 GTCTACATTC CAGATTCTCC CAAACATTCT TCATGCCTTT GCCTATACTA TCCCCTCATC 1680 CAGGAATGTG CTGTCTGCAC CACAATCAGC ACTTCCCTCA CCACCAGCAA TACACGTCAA 1740 TTATCAAGTT TCGACTATGC ATCTACACTA GGAGAGGTCC CTGCAGATAA AGAGTTTTTA 1800 GTTTGAATAT TTAAATAAAA CTTCAGCTAC CATCGGTCAT AACTGCCATC AACTCAGTCT 1860 AGTAGGAGGA TACAGGCCTG TGAACAAGTA ACTACAATAC TGTACAACCT AGGAAGGGTA 1920 TGGTAAGCTG TCACTGAGGG CTATACAAAA TCAACGTACT GTAGATGCAC TCTGAGTGGA 1980 CATGCTCAGG GGGAGAAGGG GGATCAAAAC GTATTAAAAA 2020
|